Explainable machine learning for predicting grade ≥3 treatment-related adverse events in resectable non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy: predominant contribution of hematologic toxicity
Background Neoadjuvant chemoimmunotherapy improves outcomes for resectable non-small cell lung cancer (NSCLC), but can cause severe treatment-related adverse events (TRAEs). Pretreatment models for predicting grade ≥3 TRAEs during neoadjuvant chemoimmunotherapy remain limited. This study aimed to develop and externally...